USANA Health Sciences Acquires 78.8% Stake in Hiya Health

USANA Health Sciences Acquires Rise Bar and Oola

November 28, 2022

Consumer Products

USANA Health Sciences, Inc. (NYSE: USNA) acquired two emerging health and wellness companies: Rise Bar, a protein bar manufacturer, and Oola, a direct-selling personal development company. The acquisitions are intended to expand USANA’s product portfolio, channels, and growth capabilities by leveraging the targets’ products, networks, and technology.

INVO Bioscience Acquires NAYA Biosciences; Combined Company to Operate as NAYA Biosciences

October 14, 2024

Biotechnology

INVO Bioscience has completed a reverse-triangular merger to acquire 100% of NAYA Biosciences, and the combined company will operate as NAYA Biosciences (NASDAQ: NAYA). The combined business will continue INVO's revenue-generating fertility operations while adding NAYA's clinical-stage oncology and autoimmune therapeutics pipeline and updating management and board composition.

Biogen Acquires Human Immunology Biosciences for up to $1.8B

May 22, 2024

Biotechnology

Biogen Inc. has agreed to acquire Human Immunology Biosciences (HI-Bio) for $1.15 billion upfront and up to $650 million in milestone payments, in a deal valued at up to $1.8 billion. The acquisition adds HI-Bio's lead asset felzartamab, an investigational anti-CD38 antibody with Phase 2 data in multiple renal immune-mediated diseases, to Biogen's immunology and rare-disease development capabilities.

Miura Partners Acquires HTBA (HealthTech BioActives)

November 5, 2024

Biotechnology

Miura Partners has signed an agreement to acquire HTBA (HealthTech BioActives), a Barcelona-headquartered producer of flavonoids and active vitamin B12 used across pharmaceutical, nutraceutical, food & beverage and animal nutrition markets. Miura will pursue organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients; the deal is the third investment from Miura Fund IV and is pending approval from the Spanish regulator.

GoodRx Acquires HealthiNation

April 19, 2021

Media & Entertainment

GoodRx, Inc. (NASDAQ: GDRX) announced the acquisition of HealthiNation on April 19, 2021 to expand its health content and Manufacturer Solutions offering. The purchase brings HealthiNation's library of premium health videos and editorial expertise into GoodRx to provide new ways for pharmaceutical manufacturers to reach targeted audiences and for consumers to access vetted health information.

Viveon Health Acquisition Corp. to Merge with Suneva Medical

January 12, 2022

Medical Devices

Suneva Medical, a San Diego–based regenerative aesthetics medical technology company, has entered into a definitive merger agreement with special purpose acquisition company Viveon Health Acquisition Corp. The transaction will combine Suneva with the public SPAC vehicle (NYSE American: VHAQ) to provide growth capital and public-market access for Suneva, with the combined company expected to trade on the NYSE under the symbol "RNEW."